You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

936 Results
Blog post
Working at CCO, I hear “cancer” every day. But when my doctor said to me, “I think you have cancer,” the word took on a very different meaning. I was...
Feb 2019
Document
Feb 2019
Document
Feb 2019
Document
Feb 2019
Document
Mar 2019
Document
Mar 2019
Document
Mar 2019
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Daratumumab - In Combination with Bortezomib and Dexamethasone for Relapsed Multiple Myeloma
New Drug Funding Program
    Daratumumab in Combination with a Bortezomib-Based Regimen for Newly Diagnosed Transplant Ineligible Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
daratumumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2022
Document
Mar 2019
Document
Mar 2019
Document
Mar 2019
Document
Mar 2019

Pages